Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Morgan Stanley

Ultragenyx Pharmaceutical Inc.
Start price
€34.40
10.10.23 / 50%
Target price
€84.74
10.10.24
Performance (%)
54.07%
Price
€52.00
17.09.24
Summary
This prediction is currently active. With a performance of 54.07% the BUY prediction by Morgan_Stanley is a big success. This prediction currently runs until 10.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ultragenyx Pharmaceutical Inc. 4.950% 4.950%
iShares Core DAX® 1.887% 1.967%
iShares Nasdaq 100 2.316% -1.227%
iShares Nikkei 225® 1.134% 0.390%
iShares S&P 500 1.821% 0.790%

Comments by Morgan_Stanley for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) 54.07%
Target price 84.744
Change
Ends at 10.10.24

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Morgan Stanley from $95.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat

Morgan Stanley 
0
Report Share
10.10.23

Stopped prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€36.60
03.11.23
€78.49
03.11.24
42.08%
17.09.24

Morgan Stanley 
03.11.23 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€34.60
04.08.23
€86.28
04.08.24
30.06%
05.08.24

Morgan Stanley 
04.08.23 50%